|
EBV and HLH - A Complex Relationship |
10/14/2022 - 8:30am to 9:30am EDT |
|
CLL and the CNS |
05/20/2022 - 8:30am to 9:30am EDT |
|
Chronic Lymphocytic Leukemia and Chimeric Antigen Receptor T Cells: Day by Day |
07/22/2022 - 9:10am to 10:10am EDT |
|
Case Presentations |
11/18/2022 - 8:30am to 9:30am EST |
|
Cancer Antigen Discovery and the Challenges of AML Immunotherapy |
05/27/2022 - 8:30am to 9:30am EDT |
|
Answering 'Last Week' Questions |
04/08/2022 - 8:30am to 9:30am EDT |
|
Allogeneic Conditioning Considerations for High-Risk ALL |
09/02/2022 - 8:30am to 9:30am EDT |
|
Advancing the HCT Armamentarium: Cord Expansion and SYK Inhibition |
09/16/2022 - 8:30am to 9:30am EDT |
|
Advancing the HCT Armamentarium: Cord Expansion and SYK |
09/23/2022 - 8:30am to 9:30am EDT |
|
Adult acute lymphoblastic leukemia: Modern front-line therapy and future directions |
04/22/2022 - 8:30am to 9:30am EDT |
